The Bcl-2 protein was more frequently expressed in cancer cells in patients with the intestinal type of gastric cancer than in the diffuse type, the difference being statistically significant (42/59; 71.2% versus 7/21; 25.0%, P < 0.001). This evidence concerns the gene BCL2 and cancer.